Perimeter Advances AI Breast Cancer Surgery With Claire
Toronto, Canada and Dallas, Texas, August 13, 2026 Perimeter Medical Imaging AI Inc. has announced that Intermountain Health has...
IceCure Medical
Advertisement
IceCure Highlights Cryoablation Advances in Breast Cancer Care
Caesarea, Israel, August 13, 2026 IceCure Medical Ltd., a developer of minimally invasive cryoablation technology for tumor treatment, has...
Biocon Secures Health Canada Approval for Yesintek Pen
BENGALURU, Karnataka, India, July 29, 2026 Biocon Limited has announced that its Canadian subsidiary has received Health Canada Notice...
IceCure Seeks NCCN Support for Breast Cancer Cryoablation
CAESAREA, Israel, July 29, 2026 IceCure Medical Ltd. has announced a significant development that could broaden the role of...
Movmedix Enters U.S. Market with FDA-Cleared LARS® Technology
ARC-SUR-TILLE, France, July 6, 2026 Movmedix, the French orthopedic medical technology company behind the globally recognized LARS® synthetic ligament...
Advertisements
IceCure Expands ProSense Cryoablation in Brazil After FDA Clearance
CAESAREA, Israel, July 6, 2026 IceCure Medical Ltd. has announced accelerating commercial adoption of its ProSense™ cryoablation system in...
IceCure Reports Strong 5-Year Results in Kidney Cancer
CAESAREA, Israel, March 25, 2026 IceCure Medical has reported positive five-year top-line results from its ICESECRET clinical trial, demonstrating...
IceCure Wins Israel Approval for XSense™ Cryoablation System
CAESAREA, Israel, Sept. 15, 2025 – IceCure Medical Ltd. (NASDAQ: ICCM), a pioneer in minimally invasive cryoablation therapies, today...
Advertisement
